Emerging Pathogen Alert: Novel coronavirus (2019 -nCoV) infection
The U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have released guidance documents for the management of patients known or suspected to be infected with a novel coronavirus named 2019-nCoV, which is causing pneumonia with infection associated mortality similar to SARS-CoV and MERS-CoV. The WHO recommendations are based on a 2019 interim guidance document for MERS-CoV until further epidemiologic information is available.
PDI offers several EPA-registered surface disinfectant products that have a label claim against a strain of human coronavirus (Strain 229E [ATCC VR-740]): Our products qualify for emerging viral pathogen claims per EPA’s Guidance to Registrants: Process for Making Claims Against Emerging Viral Pathogens not on EPA-Registered Disinfectant Labels’ when used in accordance with the appropriate use directions. Currently, the 2019 Novel Coronavirus has not been available for testing. These products have demonstrated effectiveness against a virus similar to 2019-nCoV on hard, nonporous surfaces. Therefore, these products can be used against the 2019-nCoV when used in accordance with the directions for use against human coronavirus on hard, nonporous surfaces.
Utilizing Tru-D® SmartUVC is an added layer of disinfection for surfaces. While there is no peer-reviewed literature that specifically focuses on the efficacy of UVC devices against this unique strain of coronavirus, Tru-D was designed to combat bacteria, viruses, spores and fungi.
At PDI, we strive to include the most relevant epidemiologically important pathogens on our disinfectant product labels and continue to monitor for emerging pathogens to be included in future product label changes.